Role of the Gut Microbiome in Metabolic Dysfunction-Associated Steatotic Liver Disease
Seminars in Liver Disease · 2024-11 · 44 (04) · 457-473
DOI: 10.1055/a-2438-4383 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Liver Disease, online erschienen am 19.11.2024. Verfasst von Salim Maher und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, St George Hospital, Sydney, Australia. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 159 Literaturangaben.
Abstract (Originalsprache)
The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD)—previously described as nonalcoholic fatty liver disease—continues to rise globally. Despite this, therapeutic measures for MASLD remain limited. Recently, there has been a growing interest in the gut microbiome's role in the pathogenesis of MASLD. Understanding this relationship may allow for the administration of therapeutics that target the gut microbiome and/or its metabolic function to alleviate MASLD development or progression. This review will discuss the interplay between the gut microbiome's structure and function in relation to the development of MASLD, assess the diagnostic yield of gut microbiome-based signatures as a noninvasive tool to identify MASLD severity, and examine current and emerging therapies targeting the gut microbiome–liver axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, St George Hospital, Sydney, Australia.
- School of Clinical Medicine, UNSW Medicine & Health, St George & Sutherland Clinical Campuses.
Zitieren
APA
Maher, S., Rajapakse, J., El-Omar, E., & Zekry, A. (2024). Role of the Gut Microbiome in Metabolic Dysfunction-Associated Steatotic Liver Disease. Seminars in Liver Disease, 44(04), 457-473. https://doi.org/10.1055/a-2438-4383
Vancouver
Maher S, Rajapakse J, El-Omar E, Zekry A. Role of the Gut Microbiome in Metabolic Dysfunction-Associated Steatotic Liver Disease. Seminars in Liver Disease. 2024;44(04):457-473. doi:10.1055/a-2438-4383
BibTeX
@article{Maher2024,
author = {Maher, Salim and Rajapakse, Jayashi and El-Omar, Emad and Zekry, Amany},
title = {Role of the Gut Microbiome in Metabolic Dysfunction-Associated Steatotic Liver Disease},
journal = {Seminars in Liver Disease},
year = {2024},
volume = {44},
number = {04},
pages = {457--473},
doi = {10.1055/a-2438-4383}
}
EUVIMED